Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Eini, Ronak ^a   Stoop, Hans ^a   Gillis, Ad J M ^a   Biermann, Katharina ^a   Dorssers, Lambert C J ^a   Looijenga, Leendert H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 145; MICRORNA 34A; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYONAL CARCINOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE MAPPING; GENE SILENCING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CARCINOMA, EMBRYONAL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HETEROGRAFTS; HUMANS; MICE; MODELS, BIOLOGICAL; OCTAMER TRANSCRIPTION FACTOR-3; RNA INTERFERENCE; SOXB1 TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896771544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083585     Document Type: Article

References (65)

1. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956. (Pubitemid 41345211)
2. Episkopou V (2005) SOX2 functions in adult neural stem cells. Trends Neurosci 28: 219-221. (Pubitemid 41556906)
3. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140. (Pubitemid 36062514)
4. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. (Pubitemid 44233629)
5. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, et al. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26: 795-797. (Pubitemid 351961456)
6. Zhang Y, Eades G, Yao Y, Li Q, Zhou Q (2012) Estrogen Receptor alpha Signaling Regulates Breast Tumor-initiating Cells by Downregulating miR-140 which Targets the Transcription Factor SOX2. J Biol Chem.
7. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, et al. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365.
8. Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, et al. (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11: 42.
9. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, et al. (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27: 40-48.
10. Lu Y, Futtner C, Rock JR, Xu X, Whitworth W, et al. (2010) Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One 5: e11022.
11. Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, et al. (2010) Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One 5: e14062.
12. Bae KM, Su Z, Frye C, McClellan S, Allan RW, et al. (2010) Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells. J Urol 183: 2045-2053.
13. Xu XL, Xing BC, Han HB, Zhao W, Hu MH, et al. (2010) The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. Carcinogenesis 31: 167-174.
14. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242.
15. Hussenet T, du Manoir S (2010) SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle 9: 1480-1486.
16. Yuan P, Kadara H, Behrens C, Tang X, Woods D, et al. (2010) Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One 5: e9112.
17. Chen Y, Shi L, Zhang L, Li R, Liang J, et al. (2008) The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283: 17969-17978.
18. Stolzenburg S, Rots MG, Beltran AS, Rivenbark AG, Yuan X, et al. (2012) Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer. Nucleic Acids Res 40: 6725-6740.
19. de Jong J, Stoop H, Gillis AJ, van Gurp RJ, van de Geijn GJ, et al. (2008) Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 215: 21-30. (Pubitemid 351619872)
20. Horwich A, Shipley J, Huddart R (2006) Testicular germ-cell cancer. Lancet 367: 754-765. (Pubitemid 43326294)
21. Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222. (Pubitemid 40314952)
22. Skakkebaek NE (1972) Possible carcinoma-in-situ of the testis. Lancet 2: 516-517.
23. Woodward PJ (2004) world health organization classification of tumours pathology and genetics of the urinary system and male genital organs. IARC Press, Lyon, PP.
24. Ulbright TM (1993) Germ cell neoplasms of the testis. Am J Surg Pathol 17: 1075-1091. (Pubitemid 23313782)
25. Masters JR, Foley CL, Bisson I, Ahmed A (2003) Cancer stem cells. BJU Int 92: 661-662. (Pubitemid 37475798)
26. Honecker F, Stoop H, Mayer F, Bokemeyer C, Castrillon DH, et al. (2006) Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol 208: 395-400. (Pubitemid 43210526)
27. Andrews PW, Matin MM, Bahrami AR, Damjanov I, Gokhale P, et al. (2005) Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. Biochem Soc Trans 33: 1526-1530. (Pubitemid 41779730)
28. Andrews PW (2002) From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci 357: 405-417. (Pubitemid 34489857)
29. Ushida H, Chano T, Minami K, Kita H, Kawakami T, et al. (2012) Therapeutic potential of SOX2 inhibition for embryonal carcinoma. J Urol 187: 1876-1881.
30. Andrews PW, Casper J, Damjanov I, Duggan-Keen M, Giwercman A, et al. (1996) Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int J Cancer 66: 806-816. (Pubitemid 26197951)
31. Damjanov I, Horvat B, Gibas Z (1993) Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT. Lab Invest 68: 220-232. (Pubitemid 23084295)
32. Damjanov I, Andrews PW (1983) Ultrastructural differentiation of a clonal human embryonal carcinoma cell line in vitro. Cancer Res 43: 2190-2198. (Pubitemid 13088762)
33. Gillis AJ, Stoop H, Biermann K, van Gurp RJ, Swartzman E, et al. (2011) Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int J Androl 34: e160-174.
34. de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, et al. (2008) Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 47: 185-196. (Pubitemid 351162849)
35. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, et al. (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
36. Oren M, Damalas A, Gottlieb T, Michael D, Taplick J, et al. (2002) Regulation of p53: intricate loops and delicate balances. Ann N Y Acad Sci 973: 374-383. (Pubitemid 36125039)
37. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
38. Wang Y, Keys DN, Au-Young JK, Chen C (2009) MicroRNAs in embryonic stem cells. J Cell Physiol 218: 251-255.
39. Walsh J, Andrews PW (2003) Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell. APMIS 111: 197-210; discussion 210-191.
40. Park SW, Lim HY, Do HJ, Sung B, Huh SH, et al. (2012) Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells. FEBS Lett 586: 3529-3535.
41. Hay DC, Sutherland L, Clark J, Burdon T (2004) Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22: 225-235. (Pubitemid 38282637)
42. de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, et al. (2005) Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 206: 242-249. (Pubitemid 40754029)
43. Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffinembedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748.
44. Looijenga LH, Smit VT, Wessels JW, Mollevanger P, Oosterhuis JW, et al. (1990) Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence. Cytogenet Cell Genet 53: 216-218. (Pubitemid 20344839)
45. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8: e1000412.
46. Nettersheim D, Gillis A, Biermann K, Looijenga LHJ, Schorle H (2011) The Seminoma Cell Line TCam-2 is Sensitive to HDAC Inhibitor Depsipeptide but Tolerates Various Other Chemotherapeutic Drugs and Loss of NANOG Expression. Genes Chromosomes & Cancer 50: 1033-1042.
47. Teshima S, Shimosato Y, Hirohashi S, Tome Y, Hayashi I, et al. (1988) Four new human germ cell tumor cell lines. Lab Invest 59: 328-336.
48. Gearhart J (1998) New potential for human embryonic stem cells. Science 282: 1061-1062. (Pubitemid 28516225)
49. Yang S, Lin G, Deng L, Lu GX (2012) Tumourigenic characteristics of embryonal carcinoma cells as a model for studying tumour progression of human embryonic stem cells. Cell Prolif 45: 299-310.
50. Andrews PW, Damjanov I, Berends J, Kumpf S, Zappavigna V, et al. (1994) Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7). Lab Invest 71: 243-251. (Pubitemid 24278177)
51. Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, et al. (2003) The new stem cell biology: something for everyone. Mol Pathol 56: 86-96. (Pubitemid 36461469)
52. Andrews PW, Fenderson B, Hakomori S (1987) Human embryonal carcinoma cells and their differentiation in culture. Int J Androl 10: 95-104. (Pubitemid 17081846)
53. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, et al. (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244-2250. (Pubitemid 36538633)
54. Hussenet T, Dali S, Exinger J, Monga B, Jost B, et al. (2010) SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 5: e8960.
55. Sharma SV, Settleman J (2007) Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev 21: 3214-3231. (Pubitemid 350277749)
56. Lim JH, Koh S, Olby NJ, Piedrahita J, Mariani CL (2012) Isolation and characterization of neural progenitor cells from adult canine brains. Am J Vet Res 73: 1963-1968.
57. Eini R, Dorssers LC, Looijenga LH (2013) Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. Int J Dev Biol 57: 319-332.
58. Jain AK, Allton K, Iacovino M, Mahen E, Milczarek RJ, et al. (2012) p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 10: e1001268.
59. Yamada N, Noguchi S, Mori T, Naoe T, Maruo K, et al. (2013) Tumorsuppressive microRNA-145 targets catenin delta-1 to regulate Wnt/beta-catenin signaling in human colon cancer cells. Cancer Lett 335: 332-342.
60. Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, et al. (2007) Highthroughput microRNAome analysis in human germ cell tumours. J Pathol 213: 319-328. (Pubitemid 350074022)
61. Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, et al. (1999) Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 4: 487-498. (Pubitemid 29531129)
62. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, et al. (2007) Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 27: 7802-7815. (Pubitemid 350086414)
63. Bauer S, Muhlenberg T, Leahy M, Hoiczyk M, Gauler T, et al. (2010) Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours. Eur Urol 57: 679-687.
64. Kersemaekers AM, Mayer F, Molier M, van Weeren PC, Oosterhuis JW, et al. (2002) Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol 20: 1551-1561. (Pubitemid 34260535)
65. Lin Y, Yang Y, Li W, Chen Q, Li J, et al. (2012) Reciprocal regulation of akt and oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol Cell 48: 627-640.